BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8316850)

  • 1. Supreme Court to judges: start thinking like scientists.
    Mervis J
    Science; 1993 Jul; 261(5117):22. PubMed ID: 8316850
    [No Abstract]   [Full Text] [Related]  

  • 2. Daubert v Merrell Dow. The Supreme Court tackles scientific evidence in the courtroom.
    Gold JA; Zaremski MJ; Lev ER; Shefrin DH
    JAMA; 1993 Dec 22-29; 270(24):2964-7. PubMed ID: 8018140
    [No Abstract]   [Full Text] [Related]  

  • 3. Court ruling on 'junk science' gives judges more say about what expert witness testimony to allow.
    Marwick C
    JAMA; 1993 Jul; 270(4):423. PubMed ID: 8320770
    [No Abstract]   [Full Text] [Related]  

  • 4. Admissibility of scientific testimony into evidence.
    Brushwood DB
    Am J Hosp Pharm; 1994 Mar; 51(5):683-5. PubMed ID: 8203391
    [No Abstract]   [Full Text] [Related]  

  • 5. Supreme Court to weigh science.
    Marshall E
    Science; 1993 Jan; 259(5095):588-90. PubMed ID: 8338515
    [No Abstract]   [Full Text] [Related]  

  • 6. Bendectin case dismissed.
    Barinaga M
    Science; 1995 Jan; 267(5195):167. PubMed ID: 7809619
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluating the admissibility of expert testimony.
    Appelbaum PS
    Hosp Community Psychiatry; 1994 Jan; 45(1):9-10. PubMed ID: 8125472
    [No Abstract]   [Full Text] [Related]  

  • 8. Two legal issues: expert witnesses and Bendectin case.
    Brushwood DB
    Drug Intell Clin Pharm; 1983 Nov; 17(11):848-9. PubMed ID: 6641512
    [No Abstract]   [Full Text] [Related]  

  • 9. Bendectin/debendox. Drug not guilty, says court.
    Beardsley T
    Nature; 1985 Mar 21-27; 314(6008):209. PubMed ID: 3982496
    [No Abstract]   [Full Text] [Related]  

  • 10. Science, law, and the search for truth in the courtroom: lessons from Daubert v. Merrell Dow.
    Bertin JE; Henifin MS
    J Law Med Ethics; 1994; 22(1):6-20. PubMed ID: 8173660
    [No Abstract]   [Full Text] [Related]  

  • 11. Daubert v. Merrell Dow: missed opportunity.
    Jackson KA
    Food Drug Law J; 1995; 50(1):71-93. PubMed ID: 10342987
    [No Abstract]   [Full Text] [Related]  

  • 12. Criteria for science in the courts.
    Nature; 1993 Apr; 362(6420):481. PubMed ID: 8464481
    [No Abstract]   [Full Text] [Related]  

  • 13. How safe is Bendectin?
    Kolata GB
    Science; 1980 Oct; 210(4469):518-9. PubMed ID: 7423201
    [No Abstract]   [Full Text] [Related]  

  • 14. Debendox in the dock.
    Brown A
    Nurs Mirror; 1980 Feb; 150(8):8-9. PubMed ID: 6899313
    [No Abstract]   [Full Text] [Related]  

  • 15. Science in the Supreme Court: round two.
    Richards EP; Walter C
    IEEE Eng Med Biol Mag; 1998; 17(2):124-5. PubMed ID: 9548091
    [No Abstract]   [Full Text] [Related]  

  • 16. The expert witness. Neither Frye nor Daubert solved the problem: what can be done?
    Kaufman HH
    Sci Justice; 2001; 41(1):7-20. PubMed ID: 11215302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA to reexamine bendectin data.
    Kolata G
    Science; 1982 Jul; 217(4557):335. PubMed ID: 7046049
    [No Abstract]   [Full Text] [Related]  

  • 18. Debendox and congenital malformations in Northern Ireland.
    Shanks RG; Griffiths K; Harron DW
    Br Med J (Clin Res Ed); 1981 Jun; 282(6280):1972-3. PubMed ID: 6786693
    [No Abstract]   [Full Text] [Related]  

  • 19. The debendox saga.
    Orme ML
    Br Med J (Clin Res Ed); 1985 Oct; 291(6500):918-9. PubMed ID: 3929963
    [No Abstract]   [Full Text] [Related]  

  • 20. More on Bendectin.
    MacMahon B
    JAMA; 1981 Jul 24-31; 246(4):371-2. PubMed ID: 7241787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.